Diabetes Management in Schools:
HB 597 revises Florida’s school health law to expand how public schools may respond to diabetes-related emergencies, especially severe hypoglycemia. The bill defines key terms such as “authorized health care practitioner,” “participating school,” and “undesignated glucagon,” and it authorizes school districts and public schools to acquire and maintain a stock supply of glucagon that is not prescribed to a specific student. Schools may obtain glucagon through purchase, donation, transfer, grants, or arrangements with manufacturers or wholesalers, and may request or receive prescriptions in the name of the school or district.
The bill also requires participating schools to make undesignated glucagon available for use under a student’s diabetes medical management plan or a health care practitioner’s orders. It directs that glucagon be stored securely but remain immediately accessible to trained personnel, requires emergency assistance and parental notification after administration, and directs the State Board of Education and Department of Health to adopt implementing rules. The bill also preserves existing student rights for carrying diabetes supplies and managing diabetes at school, while adding liability protections for school personnel, districts, health care practitioners, and pharmacists acting in good faith under the law.
HB 597 amends section 1002.20, Florida Statutes, which governs K-12 student and parent rights, by adding a more detailed framework for diabetes management in schools. It authorizes public schools and districts to stock and dispense undesignated glucagon, creates procedures for obtaining it, and establishes training, storage, notification, and rulemaking requirements. The bill also provides civil and criminal immunity for school nurses, trained school personnel, school districts, prescribing practitioners, and dispensing pharmacists when acting in compliance with the statute, thereby reducing legal risk for participants in school-based emergency diabetes care.
The bill appears to have been broadly favorable and noncontroversial in the available record. There are no committee transcripts or recorded votes included here, and the bill ultimately became chapter law, suggesting it moved through the process successfully. The overall policy direction is supportive of student health and emergency preparedness, with a focus on ensuring schools can respond quickly to diabetic emergencies.
No specific opposition or debate is reflected in the provided materials. The main policy choices embedded in the bill are operational rather than ideological: whether schools should stock a non-student-specific rescue medication, how it should be obtained and stored, and how liability should be allocated. Potential points of concern, even if not documented in the record here, would likely involve training requirements, medication handling, and the scope of immunity for school staff and medical professionals.